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Although the differential response of malignant cells 
to hyperthermia was observed at the end of the last century, 
few investigations into the phenomenon were made until 
fairly recently. At first the results obtained were incon-
sistent due mostly to the inefficient techniques in use at 
the time. The advent of cell and tissue culture, increased 
knowledge in tumor biology, advances in molecular biology, 
and the development of equipment which could raise and 
monitor the :.temperature of tumors during hyperthermic 
treatments, have made the study of the effects of supranor-
mal temperature on malignant neoplasias substantially more 
reliable. 
It has been shown that the use of hyperthermia in con-
junction with drugs (Woodall et al. , 1960; Hahn ~.! al. , 1975) 
or radiotherapy (Overgard and Okkels, 1940) enhances, in 
some cases, the effects of the treatment in an additive or 
synergystic form. Some of the drugs tested with hyperthermia 
were 5-fluoro-2'-deoxyuridine (FUDR), 1-erythro-a,S-dihydroxy-
butyraldehyde (DI-IBA), actinomycin D, DL-glyceraldehyde and 
2 deoxy-D-glucose, sodium oxamate, vinblastine, L-phenyl 
alanine mustard (PAM), 2,5-diethylenimino-3, 6-bis(2-methoxy-
ethoxy)-1,4 benzoquinone (A 139);triethylene thiophopho-
ramide (TSPA), triethylene melanine (TEM) and N-3-oxapenta-· 
methylene-N 1 ,N 1 1 -diethylene thiophosphoramide (OPSPA) 
( Giovanella et al. , 1970; Woodhall et al. , 1960). 
The effectiveness of the combined treatment of hyper-
thermia and drugs has been established. A substantial 
amount of research to ascertain the most efficient uses of 
2 
combined treatments (or for finding or screening new drugs) 
remains to be done. 
Historical Review 
1. In Vitro Experiments 
Lambert (1912) studied the effect of hyperthermia on 
normal connective tissue cells from the aorta and pulmonary 
veins of a mouse, and from a transplantable mouse sarcoma. 
Using a hanging drop plasma preparation containing actively 
proliferating cells, he observed that both types (normal 
and malignant) grew best between 37 and 39°C. Cell wandering 
and multiplication o~curred at 40 to 410C; temperatures 
above 42°C were harmful to the cultures. Damage was pro-
portional to increase in temperature and to length of 
exposure. Lambert also found that normal connective tissues 
survived from 24 to 48 hours after exposure to 42.50C, while 
sarcoma cells were destroyed. Connective tissue cells 
retained their viability after a 6-hour exposure at 430C and 
20 minutes at 460C, Sarcoma cells subjected to the same 
treatments did not survive. 
Selawri et al. (1957) compared the effects of supra-
normal temperatures on different tumors using three. cell 
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types: Hela, H. Ep.#2 (from carcinoma of the larynx) and 
J 96 (from the peripheral blood of a patient afflicted with 
monocytic leukemia). A minimum of 42~C was required to 
·cause cell death. The 3 cell lines were found to form 
thermotolerant strains when they were incubated at tempera-
tures higher than normal. These investigators also studied 
the effect of hyperthermia on the mitotic cycle of Hela 
cells. 
Burger and Furman (1964) assessed the damage caused by 
supranormal temperatures (40-47.50C) to slices of cerebral 
cortex and liver by measuring oxygen consumption, choles-
terol and ammonia accumulation and leakage of rubidium86 . 
Ammonia accumulation was found to be the most sensitive 
indicator for assessing damage. 
Sisken et al. (1965) studied the effect of temperature 
on the duration of different phases of the mitotic cycle. 
For temperatures above the 37-38°C optimum range they found 
tha~ the time throtigh metaphase was increased. The cells 
used in this experiment were from a human amnion cell line. 
Auersperg (1966) exposed human fibroblasts, obtained 
from a skin biopsy and epithelial cells from carcinoma lines 
C4 and C27, to hyperthermia. He found that· at 44 and 48°C 
both cell types responded in a similar way but that at 460C 
there was a different response that favored the viability 
of the malignant cells. The difference was most ma~ked 
after a heating period of 30 minutes; at this particular 
time the survival was approximately 70% for the carcinoma 
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cells but less than 10% for the fibroblasts. 
Cavaliere et al. (1967) found that the oxygen uptake 
of Novikoff hepatomas and Ehrlich ascites carcinoma cells 
was lower at 42°C than at ssoc; this difference was found 
to be minimal when the respiration of normal and regenerating 
liver cells was measured under the same experimental condi-
tions. 
McCormic and Penman (1968) and Palzer and Heildel-
berger (1973) found that drugs that inhibited RNA synthesis 
interfered with the recovery mechanism of cells damaged by 
exposure to hyperthermia. Fuhr (1974) used cycloheximide 
and actinomycin D to study the recovery of protein synthesis 
in murine leukemic lymphoblasts subjected to heat shock; he 
found that actinomycin D and cycloheximide. impaired this 
process when added to the cells prior to the treatment. 
Actinomycin D also impaired recovery of protein synthesis 
when added after exposure to heat. Recovery was enhanced 
when cycloheximide was present prior to and during hyper-
thermia. Fuhr also suggested that an RNA required for pro-
tein synthesis is inactivated or destroyed. 
The in vitro combined effect of drugs.and hyperthermia 
and the potential tise of this modality in the management of 
some malignancies has been studied. Giovanella et al. (1970) 
found that the simultaneous treatment of L 1210 leukemia 
cells with hyperthermia and DHBA is 100 times more effective 
than when each is applied separately. Hahn et al. (1975) 
tested the combined effect of hyperthermia with the antibiotics 
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bleomycin and adriamycin (both are currently used in the 
treatment of a variety of solid tumors) on Chinese hamster 
cells (HAl) and mouse mammary sarcoma cells (EMT-6). They 
discovered that after bleomycine exposure at 370C, the cells 
repaired potentially lethal damage and that hyperthermic 
treatment at 43°C inhibited this repair. Goss and Parson 
(1977) studied the effect of melphalan and hyperthermia 
on human melanomas and fibroblasts. They found that sensi-
tivity to melphalan was usually accompanied by sensitivity 
to heat and that the combined treatment was not only syner-
gistic in most lines but increased the differential between 
fibroblasts and melanoma cells. 
Comparative studies on the effect of supranormal tem-
perfttures on normal and transformed cells, in vitro, of 
similar or identical origin have been carried out recently 
by Kase and Hahn (1975) and Beppino et al. (1976). The 
results indicated that normal cells were more resistant to 
supranormal temperatures than transformed cells, used in the 
experimental models. These results are in disagreement with 
those of Burger and Fuhrman ( 1964). 
2. In Vivo Experiments 
One of the oldest reports in the literature linking 
hyperthermia and cancer is that of Buch (1866); he reported 
the disappearance of a sarcoma of the face after the patient 
developed high temperature during two attacks of erysipelas. 
Bruns (1887) reported a similar case; this time in a patient 
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with multiple recurrent melanomas. Coley (1893) studied the 
effect of erysipelas on patients afflicted with sarcomas and 
carcinomas. He noticed that the curative effect of erysipe-
las was systemic rather than localized and attributed this 
to the toxic products of the microorganism causing the 
disease. Coley suspected that the presence of strepto-
coccus induced the production of antibodies which eventually 
destroyed "the parasite of cancer." Westermark (1898) 
reported remissions of malignancies in patients with inop-
erable carcinoma of the cervix after treatments with hot 
water baths and local applications of heat. 
Percy (1916) succeeded in alleviating the symptoms 
and obtained a few remissions in patients suffering from 
carcinomas of the uterus after treatmment with hyperthermia 
in combination with surgery. Many of the patients who 
benefited from this treatment were in advanced stages of 
the disease. 
Overgard and ·akkels (1940) used mice to study the effect 
of diathermy on Wood's sarcoma. The temperatures used by 
these investigators ranged from 42 to 46°C. They reported 
that in most cases healing of the affected.area took place 
after tumor ulceration and breakdown. In the majority of 
the cases that failed to respond as above, at least a 
transient effect on the tumor was observed. There was no 
damage to normal tissue. The investigators also combined 
x.ray and hyperthermic treatment in an effort to inhibit 
tumor growth. They succeeded in curing afflicted mice with 
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doses of hyperthermia and radiation which would have been 
ineffective if given separately. 
Johnson (1940) developed an efficient system for the use 
of radio waves in the treatment of tumors and used it to 
study the effect of hyperthermia on the Walker rat carcinoma 
and the Jensen rat sarcoma. 
Woodal et al. (1959) reported on the effect of hyper-
thermia on the chemotherapeutic properties of certain drugs 
on external malignancies of the head and face. They perfused 
with prewarmed blood in order to raise the temperature of 
the area under treatment. The combined therapy succeeded 
in ameliorating the pain in most instances and regression of 
tumors was accomplished in half of the cases. 
Crile (1961) combined hyperthermia with anticancer 
drugs or radiation for treating some malignancies in mice. 
He failed to enhance the effect of hyperthermia with the 
drugs but was successful in destroying tumors when supra-
normal temperatures were combined with radiation; this last 
modality was also used to treat various animals and humans 
with some success. 
Cavaliere et al. (1967) treated 22 patients afflicted 
with cancer of the ·limbs with supranormal temperatures. 
Positive results were obtained i~ eight cases. Heating the 
tumors was accomplished by regional perfusion with prewarmed 
blood. 
Characteristics of Normal and Transformed 
Cells in Tissue Culture 
1. Normal cells 
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These cells have a diploid genome and can be propagated 
in culture for only a finite period of time after which they 
stop dividing and die (phase III of in vitro growth; Hay-
flick, 1966), as illustrated in Figure 1. Another charac-
teristic of these cells, in culture, is that they orient 
themselves with respect to each other and stop growing after 
they reach a certain density (contact inhibition or density 
dependent inhibition of growth). They require a fairly high 
inoculation density in order to grow and do not form tumors 
when injected into immunologically suppressed mice. 
2. Transformed and ~alignant Cells 
These cells have an aneuploid genome and can be cul-
tured, 1~ vitro, indefinitely (see Figure 1) . .If supplied 
with an adequate amount of nutrients, they will not stop 
growing when in contact with other cells and will continue 
to divide, piling up on each other. Malignant as well as 
transformed cells can grow in culture even when inoculated 
at low densities. They do not orient themselves with respect 
to the other cells in the culture and can ~form tumors when 
injected into immunologically suppressed mice. 
Purpose and Rationale of the Present 
---fi1V-e-:S"tig-a1J.on-
The purpose of this work is to compare the effect of 
hyperthermia alone and in conjunction with a drug on normal 
Figure 1. Diagramatic representation of the theory 
of in vitro cell proliferation (Hayflick 
and Moorhead, 1961). 
Figure 1 
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and transformed human lung fibroblasts. 
It has been found that the sensitivity of cells to 
hyperthermia not only changes from one cell type to another 
but also changes within a seemingly homogeneous population: 
Selawry et al. (1957) showed that cells surviving hyper-
thermic treatment could become thermotolerant, and succeeded 
in developing three different sublines with this character-
istic. The different response of cells of the same popula-
tion to supranormal temperatures could be due to adaptation, 
cell cycle dependence, or as suggested by Selawry et al., 
due to mutations. 
Bucciarite (1928) and Juul and Kemp (1933) conducted 
experiments which led them to conclude that cells were more 
sensitive to heat during mitosis than during the other 
phases of the cell cycle. It was also found by Makino and 
Nahara (1953) that the greatest damage caused by hyperthermic 
shock to cells was during metaphase. The results of these 
experiments were later confirmed by Sisken et al. (1965) 
and Westra and Dewey (1971). The other phases of the cell 
cycle Gl,S and G2 plus prophase were found to be only moder-
ately sensitive and anaphase seemed totally unaffected 
(Sisken et al. 1965). 
Thus if cells are more sensitive to supranormal tempera-
tures in metaphase than in other phases of the cell cycle, 
more actively proliferating cells should be more affected 
if exposed to hyperthermic shock than cells in interphase. 
If true, this would provide us with an acceptable explanation 
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for the increased sensitivity of malignant cells to supra-
normal temperatures. However, it has been shown by Beppino 
et al. (1976) that some normal cells dividing at a faster 
rate than their transformed counterparts were still more 
resistant to hyperthermic treatment than the malignant cells. 
In searching for a treatment which would favor the 
survival of cells in resting, Go or Gl phase, we decided to 
increase the number of transformed cells in the mitotic 
state, with a drug, prior to the use of hyperthermia. 
If the drug was administered in vivo it should stop 
actively dividing cells in mitosis. Although the clinical 
effect would be systemic, hyperthermia could be applied on 
a localized basis only. The normal cells of tissues sur-
rounding a given tumor would be, for the most part, in a 
contact-inhibited state and as far as an increase in the 
mitotic index, they would be refractile to the action of the 
drug. The final result would be a tumor with a greater than 
normal nmnber of cells in mitosis and a surrounding tissue 
practically undisturbed, except in the case of tumors grow-
ing at the site of actively proliferating normal cells. 
MATERIALS AND METHODS 
The cells used'in these experiments were human embryonic 
lung cells (WI-38 and WI-38 Simian virus 40 transformed 
VA-l3/2RA), purchased from the American Type Culture Collec-
tion (Rockville, MD). 
Origin of the Cells Used 
l. WI-38 Cells 
These cells were originally cultured by Dr. L. Hay-
flick (1964) from a three-month old fetus following a surgi-
cal abortion. He isolated the cells by tearing or mincing 
the lung tissue in a petri dish containing Eagle's medium 
and placing the fragments (l-4mm3 ) in bottles with a surface 
f 2 area o 100 em When growth was observed, the old medium 
containing the fragments was removed, and replaced by fresh 
nutrient medium. Subculturing of the cells was made when 
they reached confluency approximately after 10 days. As 
soon as the cells became confluent, they were put on a 
strict schedule of subcultivation. Hayflick preserved the 
cells by freezing a suspension of l.5-2Xl06 cellsjml in a 
medium containing 10% sterile glycerol. The suspension was 
dispensed as 2ml aliquots in 5ml ampules. After sealing, 
the ampules were kept at 5°C overnight and then placed in a 
deep freeze at -70°C. 
In our laboratory, the :frozen cells were reconstituted 
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by vigorously shaking the ampules in a 37°C water bath and 
by transferring the thawed contents into a T-25 flask con-
taining basal medium Eagle (BME) with 10% serum warmed up 
to 37°C. After 24 .hours, the fluid was removed from the 
flask and replaced with fresh medium. After the cells 
reached a confluent state, the cultures were split in halves 
and transferred to T-60 flasks. This procedure was repeated 
every four days. 
2. Transformed Cells (VA-13/2RA) 
Girardi et al. (1966) transformed the WI-38 cells 
during phase II of their in vitro life span by exposing them 
to SV-40. The onset of transformation was considered to be 
the time of contact inhibition loss (see Figure 1). These 
cells were thawed in our laboratory in the same manner 
described for WI-38 cells. 
Drug Used in These Experiments 
The drug used· in these experiments was vinblastine 
1 sulfate, formerly called vincaleukoblastine (VLB). The 
drug has been shown to be a mitotic poison with an action 
similar to that of vincristine, colchicine and colcemide. 
Biopsided non-responsive tumors, from patients treated with 
VLB, still show large numbers of cells in metaphase. This 
seems to indicate that metaphase arrest is not the only 
way in which VLB inhibits tumor growth. There is some 
1Grand Island Biological Co.; Grand Island, N.Y. 
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evidence pointing to an antimetabolic activity: the drug 
seems to interfere with the pathway of aminoacids leading 
from glutamic acid to the citric acid cycle and to urea. 
Routine Stock Maintenance 
The two cell types used in these experiments were 
propagated in BME 90%, and 10% fetal calf serum (complete 
medium), micoplasma tested and virus screened. The media 
was sterilized by using a filter, pore size 0.22~m, and 
was stored at 3°C; the sera was stored in volumes of 3 to 
0 7 ml. at -4 C. One hundred units of penicillin and lOO~gjml 
of streptomycin were added to each container of medium 
before use. WI-38 cell populations were split in a 1 to 2 
ratio every four days with no intervening feedings. This 
was accomplished by removing the used medium and rinsing the 
confluent cell layer 2 times with Ca-Mg- free phosphate 
buffer saline (CMF-PBS) prewarmed at 37°C. The first rinse 
was removed after five minutes and the second after approxi-
mately 30 seconds. Three ml of trypsin were added to the 
flasks to be subcultured; the trypsin used was Difco 1:2502 
and was prepared as a stock solution 4X strength. It was 
filtered through an 0.22 ~m millipore filt~r and stored in 
test tubes in 5-7 rnl aliquots, at 4°C. The trypsin solution 
was allowed to act on the cells for one minute and then it 
was removed; residual trypsin was allowed to work for an 
additional 3-·9 minutes before 10 ml of medium (prewarmed at 
2Difco Laboratories Incorporated; Detroit, Michigan. 
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37°C) were added to the flasks in order to rinse the par-
tially detached cells. This process was repeated twice, 
and then, by means of a pipette, the cells were forced up 
and down against the walls of the container until they were 
dispersed. Five ml of this suspension were delivered into 
a second flask; then the total volume, for each flask, was 
brought to 10 ml by adding 4 ml of medium and 1 ml of serum, 
prewarmed at 37°C. The inoculated flasks were gassed with 
air containing 5% C02 filtered through glass wool. The 
cells were then incubated at 37°C. The stock cells were 
propagated in T-60 pyrex flasks. 
An almost identical method was used in the cultivation 
of the VA-13/2RA cells, the only difference being that the 
dispersion was accomplished in only 9 ml of medium and 1. 5-2 ml 
of this suspension were used to seed other T-60 flasks; the 
final volume was 10 ml. These cells were subjected to a 
total medium exchange 3 days after inoculation and were 
subcultured every five days. 
Proce~ure Used for Studying Acute 
~.!._ortali ty 
In these studies WI-38 and VA-13/2RA qells in log phase 
were exposed to hyperthermia. Two of the T-60 flask cultures 
were suspended, after trypsinization, in complete medium 
in the volumes required to obtain a 5.56-9.58X 103 cellsjml. 
The cells were counted by using a Coulter counter model B. 
Eighteen Carrel flasks (or more) were inoculated with 
a Cornwell syringe (one ml of cell suspension .in each flask). 
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The flasks containing the WI-38 cells were subjected to 
hyperthermic treatment after three days of incubation at 
0 37 C, by immersing them in a water bath to raise the tern-
perature of the cells. Previous to immersion in the water 
bath, the medium was removed and replaced with Hank's 
balanced salt solution. The temperature was controlled to 
~ 0.2°C with a water thermostat. Three flasks at a time 
were removed at random from the water bath at the intervals 
indicated in the results and the cells were stained with 
0.05 ml of 0.4% erythrosin B solution for each ml 'of cell 
suspension (Phillips and Terryberry., 1957). The flasks 
were then incubated for 5 minutes at 37°C. The cells were 
counted under a green filter using a phase contrast Nikon 
model M microscope. The counts were made by moving the 
flasks at random and counting the cells in the area marked 
on the ocular; 100 or more cells were counted from each of 
the three flasks. Unstained cells were considered living, 
while stained cells were considered dead. The percent 
survival was calculated as shown in the results. VA-13/2RA 
cells were treated exactly as the WI-38 cells except that 
hyperthermic treatment was given 24 hours after inoculation. 
Because the cells were heated in Hank's balanced salt solu-
tion a control experiment was run to control the tolerance 
of the cells to it when incubated at 37°C for different 
lengths of time. 
Each experiment was run at least twice; three flasks 
were used in order to determine the percent survival after 
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after exposure. The second test 1 run for the purpose of 
checking on the reproducibility of the results was also 
designed to add or complement the first test. All readings 
were considered in the final average obtained unless sta-
tistically proven to be an aberrant extreme value (see 
graph in Figures 3 1 4 or Tables V and VI in the Appendix). 
Determination of the Drug Concentration 
to be Used in These Experiments 
The concentration of VLB to be used in the treatment 
of the cells in these experiments was determined by exposing 
the transformed cells to different concentrations of the 
drug for different lengths of time and determining the per-
centa.ge of mitoses. Cells were considered in mitosis when 
they adopted the characteristic round shape of cells under-
going division. Over 100 cells were counted from each one 
of a duplicate set of flasks and the whole test was run 
twice. The concentration of the drug to be used in this 
experiment was determined by observing the increased number 
of mitoses and the cyto-toxicity caused by the different 
concentrations (see Table 1 in Appendix). 
Procedure Used for Studying the 
Delayed Effect of Hyperthermia 
and/or VLB 
1. In these studies WI-38 and VA-13/2RA cells growing 
logarithmically were treated. The effect of hyperthermia 
and the drug was assessed by measuring growth after exposure 
of the cells to the selected treatments. 
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The results were expressed as percent growth as com-
pared to the untreated controls. The untreated controls 
were assigned a 100% growth value. Four replicate cultures 
in T-60 flasks containing transformed cells in log phase 
(24 hours after inoculation) and four replicate cultures of 
normal cells growing logarithmically (72 hours after inocu-
lation), were used for this part of the experiment. The 
medium was removed from all four flasks and replaced with 
10 ml of complete medium in the two control flasks and by 
medium plus O.lvg of VLB/ml in the other two. The desired 
concentration of the drug was obtained by serial dilutions 
of the original solution. The four T-60 flasks were incu-
bated for an additional 24 hours at 37°C. At the end of 
this period the medium was carefully removed with a 10 ml 
pipette and was centrifuged at 1000 rpm for 5 minutes. In 
the meantime, 5 ml of CMF-PBS were added to each one of the 
flasks from which the medium was removed. The cell free 
supernatant was discarded and the 5 ml of CMF-PBS were 
removed from the T-60 flasks and were used to resuspend the 
cells in the centtifuge tubes (mostly detached and in 
mitoses). The suspension was centrifuged ~gain, the cells 
resuspended in 3 ml CMF-PBS and put into the original flasks. 
One ml. of trypsin was added to each one of the T-60 flasks. 
Immediately after they were incubated for 5-10 minutes at 
room temperature, the cells were dispersed and transferred 
to a centrifuge tube containing 4 ml of CMF-PBS. The cell 
suspension was centrifuged, the supernatant discarded and 
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the cells resuspended in 10 ml of medium. Immediately 
after suspension was accomplished, the medium containing 
cells was transferred to the corresponding flasks and was 
used to suspend the cells which still remained attached. 
This procedure was designed to minimize cell loss, and was 
particularly important in the case of the two flasks treated 
with VLB, since this drug blocks mitosis at metaphase. Cells 
in metaphase often detach from the glass surface and float 
about in the medium. Had the old medium been discarded (as 
is done when cells are routinely sub-cultured) many metaphase 
cells would have been lost, thus altering the final results 
(see Table 1). 
The four T-60 flasks that were used in each experiment 
were obtained from a single 5-day culture or two 4-day cul-
tures for the VA-13/2RA and WI-38 cells, respectively. The 
flasks were trypsinized and the cell number adjusted to 
5.4-7.0 X 103 cellsjml for the transformed line and between 
5.8-6.7 X 103 cell'sjml for the normal strain, previous to 
inoculation into the four replicate T-60 flasks. Inocula-
tion was accomplished by means of a 10 ml Cornwell syringe, 
All cell counts were made with a Coulter counter. The cell 
suspensions were pooled into two groups: A) in which the 
contents of the two flasks were untreated, and B) in which 
the contents of the two remaining flasks ~~re treated with 
VLB. The pooled suspension of A and B were transfe~red to 
two 100 ml Erlenmayer flasks (contents of A and B were kept 
separate). Replicate T-15 flasks were prepared by inoculating 
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the contents of flasks A and B into two separate groups by 
means of a 2 ml Cornwell syringe. The replicate T-15 
flasks were gassed (air 95% + co2 5%) and incubated for 
15 minutes at 37°C. Each test was run at least twice and 
2 or 3 flasks were used for each data point. It was experi-
mentally demonstrated that 43°C for 1/2 hour was a suitable 
temperature and length of exposure for the purposes of 
this experiment. Some flasks were exposed to 40°C for 14 
hours. 
After incubation of the replicate cultures for 15 min-
utes at 37°C, the flasks to be treated were immersed in a 
water bath at 43°C for 1/2 hour. At the end of the treat-
ment they were taken out as quickly as possible and the 
flasks to be exposed to a second temperature (40°C for 14 
hours) were re-immersed immediately after the temperature 
was lowered. Lowering of the temperature was accomplished 
by adding ice cold water to the bath. The desired tempera-
ture was attained ·in less than 5 minutes. The remaining 
flasks were put in the incubator at 37°C. 
All flasks were trypsinized three days after the begin-
ning of the hyperthermic treatment and the cells were counted 
in the electronic counter. 
2. In these studies confluent WI-38 and three days VA-13/2RA 
cells were treated. This part of the experiment was basically 
very similar to that previously described. The density of 
the cells inoculated in the four replicate flasks at the 
Table I. Diagram of the procedures used to test the 
delayed effect of supranorma1 temperatures, 
and or vinblastine sulfate, on normal and 
transformed cells. 
Table 1 
VA-l3/2RA Third Day Growth 
WI-38 Confluent Cells 
Equal number of cells inoc-
ulated into T-60 flasks 
Control Flasks Test Flasks 
' ' Cells inoculated 








Cells suspended and centri-
fuged to rescue floaters 
(see text). Cells inocu-
lated into T-15 
J I fla1 
Cells inoculated for 15 
Minltes at 37fC 













VA-13 Log Growing 
WI-38 Log Growing 
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Equal number of cells inoc-
ulated into T-60 flasks 
Control Flasks Test Flasks 
' ' Cells inoculated WI-38 in log phase 











Cells suspended and centri-
fuged to rescue floaters 
(see text). Cells inocu-
lat:r into T[1s flask]; 
Cell~ inoculated for 15 
MinuJes at 37oc 1· 
Cells were slbject to hyper-
thermic treatments (except 
controls) l J 
Cel~ were c unted 4 days 
after hyperthermia treatment 
r 
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beginning of the experiment, ranged between 1.0-1.2 x 105 
cellsfml in the case of the WI-38 cells and between 8.0-9.0 
X 104 in the case of the VA-13/2RA cells. The VLB treat-
ments (same concentration as in the previous experiments) 
were given on day 3 and 4 to the transformed and normal 
cells respectively; the exposure time was 48 hours. The 
medium containing the drug and some floating cells was 
removed and centrifuged in order to rescue the floaters. 
The procedures leading to the inoculation of the replicate 
T-15 flasks were almost identical with those of the previous 
experiment: the exception being that of the solution made 
previous to the plateing of the replicate culture flasks. 
In this experiment the treated cells in the T-60 flasks 
were confluent and very numerous: low inoculations were 
required at the beginning of the experiment to allow enough 
space for the cells to grow. For this reason their content 
was diluted 1:6 and 1:4, for the VA-13/2RA and WI-38 cells 
respectively, just prior to seeding (see Table 1). 
Quantification of Results 
The cells in 2 or 3 flasks were counted for each one 
of the treatments in this experiment. The·contents of each 
T-15 flask were suspended in 1 ml of trypsin and were added 
to 9 ml of counting solution (0.9% NaCl and 0.01% sodium 
azide). Four to 6 readings were made for each flask. The 
counts were averaged and the percent growth was obtained 
from this value. The mean of the readings obtained for the 
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control group was considered to be 100% growth. Since 
each experiment was done at least twice, 4 or more readings 
were made (as a percent value). The average of all these 
counts was considered to be the final result for each 
different treatment. If extreme .values were observed, they 
were subjected to statistical tests for extreme values at a 
probability level of 0.05; the value was discarded only if 
the results exceeded the 95% confidence limit (Bliss and 
Calhoun, 1954). 
RESULTS 
Assessment of the Percent Survival 
with a Vital Stain 
Cell counts, in this part of the experiment, were made 
within the flasks without the need of trypsinization. This 
precaution was taken to avoid subjecting the cells to a 
variable other than the hyperthermic treatment. This tech-
nique was a modification of the staining procedure used by 
Phillips and Terryberry (1957). It was for this reason that 
an experimental control was used to see whether or not long 
exposures of these cells to HBSS would have any detrimental 
effect on their survival. Tables 2 and 3 (see Appendix) 
show that even after exposures of 16 hours, more than 90% 
of the cells remained alive. 
Growth Characteristics of WI-38 
and VA-i3/2RA Cells 
The graph in Figure 2 compares the growth of both WI-38 
and VA-13/2RA cells. WI-38 cells pass through a lag phase 
prior to entering the logarithmic phase of growth. It was 
observed, in preliminary experiments, that when the drug 
was added during the lag phase, many cells died: adding 
the drug at this time was putting too much strain on cells 
trying to regain their vigor after subcultivation. Because 
of this, it was decided to treat the cells on day 3 after 
inoculation. The VA-13/2RA cells, on the other hand, were 
more resistant: they attached and began to divide readily. 
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No enhancement of drug-induced damage was observed when the 
cells were exposed to VLB 24 hours after seeding. Since 
these cells grow so fast, and their survival had to be 
assessed optically, the count had to be done before the 
cell population became too dense. 
Another characteristic of the growth curves is that 
VA-13/2RA cells continue to grow at a higher rate than WI-38 
cells, which reach a plateau or a confluent state after 
75 hours. 
Drug Sensitivity of the Transformed Cells 
Table 1 (Appendix) shows the response of the cells 
(VA-13/2RA) to different concentrations of the drug and to 
different times of exposure. Concentrations higher than 
0. 1 pg/ml proved to be too toxic for the purposes of this 
experiment. Toxicity was apparent in the form of granula-
tions, dented margins, lysed cells and bleb formation. 
Although some degree of toxicity was observed at 0.1 pgjml, 
it was considered acceptable on the basis of evidence 
gathered from microscopic observations. Cells continued to 
divide and maintained most of their healthy characteristics 
such as shape, attachment, growth, etc. 
After 24 hours of exposure to the drug (0.1 vgfml), a 
marked increase in the mitotic index of the cell population 
could be observed. The mitotic block seemed to decrease 
somewhat after 48 hours. A similar situation seems to occur 
for 0.01 and 0.001 pgjml. 
Figure 2. Growth curve: normal and transformed 
human lung fibroblasts (WI-38 and 
VA-13/2 RA). 
The vertical bars in this and the other 
graphs show the spread of the readings 
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Comparison of the percent survival of WI-38 and VA-13/2RA 
cells reveals a marked difference in the response of these 
cells to hyperthermic shock (Table 5 in Appendix). Between 
2 and 5 hours appear to be the exposure time at which the 
transformed cells begin to show a marked diminution in sur-
vival at 44°C (Figure 3)~ A similar decrease in survival, 
at this temperature, was observed for normal cells between 
the fifth and the sixth hour of exposure. After 9-1/2 hours 
the number of WI-38 cells surviving, ranges between 50 and 
80%, whereas for the same time and exposure, the VA-13/2RA 
cells surviving, range between 10 and 30%. 
Table 5 (Appendix) and the graph in Figure 4 show the 
differential response of the cellular system exposed to 
46°C. The transformed cells show the detrimental effect 
of supranormal temperatures soon after one hour of exposure. 
WI-38 cells begin to show a similar effect only after 2 hours 
of exposure. The detrimental effect is, however, less 
marked than in the previous case. After 5 hours of hyper-
thermia, less than 10% of the transformed cells still 
remained alive compared to 40 and 60% of the WI-38 cells. 
Delayed Damage to Cells Induced 
by Hyperthermia and VLB 
In Table 7 (see Appendix) and Figure 5, the differential 
response of the normal and transformed cells to hyperthermia 
can be observed. In this particular instance, the response 
Figure 3. Percent survival of normal and transformed 
cells after hyperthermic treatment (44°C) 
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Figure 4. Percent survival of normal and transformed 
cells after hyperthermic treatment (46°C) 
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Figure 5. Delayed effect of hyperthermia andjor 
vinblastine sulfate on normal and trans-
formed human lung fibroblasts. 
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The drug was added 96 hours 
after inoculation (ce11s confluent). 
Exposure lasted 48 hours and growth 
was asResRed 4 days after treatment. 
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was measured as percent growth 4 days after the treatments 
had been completed. This was done in order to take into 
account the delayed effect of heat upon the cells. 
A comparison is made of the growth response of both 
types of cells in two different stages of their life in 
vitro: log and confluent WI-38 and log and third day growth 
VA-13/2RA cells. The results show that the transformed 
cells respond similarly when exposed to 43°C for 1/2 hour, 
24 or 72 hours after they had been inoculated. The same 
holds true for the WI-38 cells that were in log phase of 
growth or in a confluent state before exposure. Also, 
the VA-13/2RA cells showed less growth, under the same 
treatments, than the normal cells. 
DISCUSSION 
The experimental results reported here support the find-
ings of several investigators who found that in general, 
cells derived from tumors and transformed cultured cells are 
more sensitive to hyperthermia than normal cells in vitro. 
Beppino et al'(l976) made a comparison of the effects 
of hyperthermia on normal and malignant cells in vitro. 
They compared the sensitivity of several normal cell types 
with that of their transformed equivalents. Their methods 
and design were similar to those we used. From our results, 
summartzed in Figure 3 (exposure to 44°C and Figure 4 (ex-
posure to 46°C), it can be concluded that cell mortality 
is proportional to the increase in temperature and length 
of exposure. Beppino et al obtained similar results with 
0 cells at 42.5-43 C. 
As seen in Figure 5, the transformed cells in the log 
phase that were exposed to 43°C for 30 minutes and th~n 
incubated at 37°C (for 4 days) showed only a 44% growth as 
compared to that of the controls. Identically treated log 
phase WI-38 cells show~d 79% growth as compared to the con-
trols. A similar result was obs~rved in the experiment 
' 
corresponding to the 3-day growth of VA-13/2RA and confluent 
WI-38 cells; the values were 46 and 77%, respectively. 
These results confirm the conclusion reached in the acute 
mortality studies and are in agreement with those found by 
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Kase and Hahn (1975) who used a completely different experi-
mental design. It seems safe to conclude, therefore, that 
the virus-transformed WI-38 cells are intrinsically more 
sensitive to hyperthermia than the normal WI-38 cells. The 
above conclusion applies to acute mortality and to delayed 
effects of supranormal temperatures, in the experimental 
model used. 
When low grade (40°C) hyperthermic treatment is used 
as it was by Giovanella et al. ( 1970) for leukemic cells 
(L-1210) in vitro, we found that after 14 hours exposure, 
there was a significant decrease in the survival of the 
transformed cells. The growth of the transformed cells, 
in log phase, was found to be 26% of the control, substan-
tially less than that obtained for the WI-38 cells under 
identical experimental conditions (80%). The results ob-
tained for the three day growth of transformed and confluent 
normal cells in this same phase of the experiment were 
similar, but somewhat less pronounced (41% for the trans-
formed cells and 86% for the normal). Under the experimental 
conditions followed in ':t.his laboratory this particular treat-
ment was by far the most effective in producing results 
that favored the survival of normal cells. A statistical 
analysis of the results reveals a significant difference 
between the two groups (0.05 level of confidence) for the 
three day growth of VA-13/2RA and confluent WI-38 cells, and 
a highly significant difference (0.01 level of significance) 
for the log phase WI-38 and VA-13 cells. 
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When the results of the log phase cells are compared 
with those of the confluent or three day growth cells, for 
each treatment, a close correspondence can be seen. The 
differences, except for one exposure, were almost the same. 
When the cells were treated only with VLB, during the log 
phase of growth, a significantly different and unexpected 
result was obtained. The transformed VA-13 cells were more 
resistant to the toxic effects of VLB than the normal WI-38 
cells .. 
Johnson et al. (1960) suggested that the oncolytic 
effect of the drug was due to its interference with the meta-
bolic pathway leading from glutamic acid to urea and from 
glutamic acid to the citric acid cycle. Vaikenicius et al. 
(1972) made cytologic observations of responsive and non-
responsive tumors and could not predict the outcome of the 
treatment just by observing the relative number of mitoses 
in the tissues studied. However, they noticed in some of 
the regressions a considerable amount of hemorrhaging simi-
lar to that described for tumors regressing after colchicine 
treatment. It is our opinion that even if tumor cells are 
not seriously affected by VLB, regression of the malignancy 
could occur as the ·result of the effect of the drug on the 
cells taking part in the process bf vascularization of the 
tumors. Normal vascular cells would be the target of the 
drug, and in some instances, the cause of the regression. 
When the 3-day growth transformed cells are compared, 
for their response to VLB, against the confluent WI-38 cells, 
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no significant difference is found. These results suggest 
a decreased sensitivity of the normal cells to the drug, 
when confluent. 
The results in Fig. 5 suggest that the expected 
increased ratio of normal to transformed cells, when the 
treatment was VLB plus hyperthermia, did not occur. These 
results seem to indicate·that the cells used in this experi-
ment are not more sensitive to hyperthermia, during mitosis, 
as was true for the cells studied by Bucciante (1928), Juul 
and Kemp (1933), Makino and Nahara (1953) and others. Pos-
sibly the benefits obtained by the mitotically less active 
normal cells, when subject to hyperthermia, were cancelled 
out by its higher sensitivity to the effect of the drug, 
as suggested by the results in Figure 5. 
Possible Mechanisms of Hyperthermic Damage 
Supranormal temperatures may affect the activity of 
enzymes according to their susceptibility to alteration. 
Enzyme denaturation due to supranormal temperatures is one 
of the possible causes of cell damage (Giese, 1973). Giese 
noted that DNA is not affected in this respect by tempera-
tures below 70°C and, consequently, it should be overlooked 
as a cause of cell damage at the temperatures used in this 
research. RNA seems to be the most likely of the macro-
molecules to be damaged by hyperthermia. When the ribosomes 
of the thermophile Bacillus stearothermophilus were compared 
with those of the mesophile E. Co_li, for heat sensitivity, 
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it was found that the ribosomes of ~· Stearothermophilus 
were more resistant than those of E. Coli. Tests showed 
that the protein moiety of the ribosomes that were heat 
resistant was as heat labile as that of the ribosomes from 
E. Coli. It has been found that the polyamines from the 
thermophile did not protect the ribosomes of the mesophile 
from high temperatures. Ribosomal RNA from E. Coli begins 
to show some instability at about 43°C whereas that of B. 
Stearothermophilus is still stable up to about 65 to 70°C. 
(Mangiotini et al. 1965). 
The decrease in the rate of amino acid' incorporation 
noticed in several investigations has been traced to poly~ 
ribosome disaggregation (McCormick and Penman, 1969); the 
damage incurred by these aggregates was not irreversible 
at •12°C in Hela cells. Normalization of protein synthesis 
was restored by re-incubation of the treated cells at 37°C 
and only partially restored when they were maintained at 
42°C for more than 10 minutes. 0 Recovery at 42 C was shown 
to be dependent on RNA synthesis. McCormick and Penman 
has postulated that a particular type of RNA, sensitive to 
hyperthermia, is synthesized by the cells in response to 
depressed protein syntehsis. This RNA would promote the 
association of ribosomes into polyribosomes and would be 
part of the normal mechanism of the cells for the regulation 
of protein translation. 
Inhibition of protein synthesis in Hela cells by the 
drug actidione was shown to protect cells against polyribosome 
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disaggregation. Cells were not protected when DNA dependent 
RNA synthesis was blocked with actinomycin D. Further evi-
dence pointing towards a heat labile RNA species is provided 
by reticulocytes; cells in which RNA synthesis is no longer 
possible. When these cells are subject to hyperthermic 
shock, protein synthesis is inhibited and recovery never 
occurs (Fuh~ 1974). There is still another important cell 
component which might be involved in heat induced damage; 
there is some evidence pointing to cell membrane disruption 
as the cause of cell death. The stored lipids of animals 
adapted to high temperatures have a higher melting point 
than those of the non--adapted controls. The drug adriamycin 
enters into Chinese hamster cells (HAI) much more easily at 
43 than at 47°C indicating a heat induced modification in 
the permeability of the cell membrane (Hahn ~ ~1. , 1975). 
Possibilities of Hyperthermia for 
the Treatment of Cancer 
A general picture of the positive and negative aspects 
of the use of hyperthermia as a tool for the treatment of 
some types of cancers is beginning to emerge: Selawry et al 
(1957) and McCormick and Penman (1969) warn against the pos-
sibility of creating temperature resistant tumors after 
failing to completely destroy the malignancies with the 
first treatments. We have also learned that tumors will 
heat up more easily than the surrounding tissues (Leevine 
et al., 1976) and that hyperthermic treatments can be useful 
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in combination with radiation (Overgard and Okkels, 1940; 
Hoeffer et al., 1976). We have also mentioned that supra-
normal temperatures in combination with drugs can be used~ 
successfully, for the treatment of some malignancies. Har-
ris (1976) warns against a possible decrease in the activity 
of the Cytotoxic T-lymphocytes after exposure to supranormal 
temperatures. 
One of the results of our research suggests a new 
mechanism for the therapeutical activity of VLB on tumors. 
Tumors heat up easier than normal tissues by virtue of their 
inefficient blood flow. If VLB impairs the vascular supply 
to the neoplasm even more, the hyperthermic damage would 
increase. 
Based on available data, it is safe to assume that 
the clinical use of hyperthermia, alone or in combination 
with drugs, x-rays, surgery and immuno therapy will be 
effective for the treatment of some malignancies. 
SUMMARY 
1. The effect of supranormal temperature and vinblastine 
sulfate on normal WI-38 and transformed VA-13/2RA cells 
has been investigated. 
2. It was found that the transformed cells were more sen-
sitive to supranormal temperature, both in their immedi-
ate and delayed response. 
3. Vinblastine sulfate impaired the growth of normal cells 
more than that of malignant cells when they were both 
growing.logarithmically. 
4. The combination of vinblastine sulfate plus hyperthermia 
did not produce an increased ratio of surviving normal 
versus transformed cells. 
5. The highest normal/transformed ratio, for the cellular 
0 system used, was found to be 40 C for 14 hours. 
6. It is possible that tumor regression after vinblastine 
treatment might be, in some cases, due to the action of 
the drug on the host 1 s vascular tissue. Impairment of 
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The Effect of Vinblastine Sulfate on the Percentage of 
Mitoses in a VA-13/2RA Cell Culture 
Exposure Time in Hours 
24 28 72 
Percent of Cells in 
Mitosis 
Control Test: Run Number l 6.9 6.0 6.3 
Control Test: Ruri Number 2 3.3 4.5 4,5 
Vinblastine Treatments 
" ln f.lg/m~ 
0.1 39.0 29.8 20.8 
0.01 34.0 30,4 18.0 
0.001 21.8 13.7 13.1 
0.001 25.8 14.0 20.2 
0.0001 8.4 10.5 7.0 
0.0001 5.0 10.0 11.9 
Table II 
Tolerance of VA-13/2RA Cells to 
Hank's Balanced Salt Solution 
Exposure Time in Hours Flask N° 1 2 3 
Pe.rcent Survival 
0 98 96 95 
1 97 97 97 
2 98 92 90 
4 98 97 90 
6 95 93 93 
16 94 93 92 
Percent survival - (Surviving cells/number of cells 












Tolerance of WI-38 Cells to Hank's 
Balanced Salt Solution 
Flask N° 1 2 3 
Exposure Time in 
Hours and Minutes Percent Survival 
0 98 99 100 
0 99 100 97 
1 94 100 94 
2 98 97 97 
3 98 99 98 
3 98 95 100 
6:35 98 98 98 
7 96 98 95 
9:40 96 95 98 
10 97 98 98 































Growth Curve of VA-13/2RA 
and WI-38 Cells 
55 
Cell number X 102 
VA-13/2RA Cells 
WI-38 Cells 17th Passage 



















Tolerance of WI-38 and VA-13/2RA 
Cells to 44°C 
56 
Hours and Minutes 






































































*Survival was measured immediately after exposure. 
Table VI 
Tolerance of WI-38 and VA-13/2RA 
Cells to 46°C 
57 
Hours and Minutes 






















































*Survival was measured immediately after exposure. 
58 
Table VII 
Delayed Response of Logarithmically Growing WI-38 
and VA-13/2RA Cells to Hyperthermia and'VLB 
Treatment Percent Growth Average 
WI-38 




B. 43°C for 1/2 22 15 
Hour and 400C 13 
for 14 Hours 13 
10 




D. VLB for 33 38 
24 Hours 40 
37 
40 
E. VLB for 24 Hours 24 28.5 
43oc for 1/2 Hour 30 
30 
30 
F. VLB for 24 Hours 8 12 
43oc for 1/2 Hour 15 
400C for 14 Hours 14 
G. VLB for 24 Hours 35 22 











Table VII. (continued) 
Treatment Percent Growth Average 
(VA-13/2RA) 
B. 43°C for 1/2 10 10.3 
Hour and 400C 11 
for 14 Hours 10 




D. VLB for 64 
24 Hours 58 
49 
D. VLB for 57 56 
24 Hours 57 
62 
44 
E. VLB for 24 Hours 45 37 






F. VLB for 24 Hours 7.9 7 
43°C for 1/2 hour 8.0 
4ooc for 14 Hours 6.0 
7.0 
G. VLB for 24 Hours 10 10 










Delayed Response of Confluent WI-38 and Third Day 
Growth VA-13/2RA Cells to Hyperthermia 
and VLB 
Treatment Percent Growth Average 
WI-38 





43°C for 1/2 25 21 
Hour and 4ooc 19 









VLB for 52 40 





VLB for 48 Hours 30 35 





VLB for 48 Hours 21 14 
430C for 1/2 Hour 20 






Table VIII. (continued) 
Treatment Percent Growth Average 
G. VLB for 48 Hours 26 29 














B. 43°C for 1;'2 31 22 
Hour and 4ooc 28 














D. VLB for 65 53 






Table VIII. (continued 
Treatment Percent Growth Average 
E. VLB for 48 Hours 40 32 





F. VLB for 48 Hours 15 10 
43oc for 1/2 Hour 16 







G. VLB for 48 Hours 65 53 
4ooc for 14 Hours 58 
53 
47 
41 
